Stockreport

bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress

bluebird bio, Inc.  (BLUE) 
Last bluebird bio, inc. earnings: 2/18 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.bluebirdbio.com/investor-overview
PDF - Continued strong commercial launch for ZYNTEGLO® and SKYSONA®; 7 patient starts (cell collections) across both programs to date -- Update on Biologics License Applicat [Read more]